دورية أكاديمية
A randomised, placebo-controlled, Phase II, dose-ranging trial of once-daily treatment with olodaterol, a novel long-acting β2-agonist, for 4 weeks in patients with chronic obstructive pulmonary disease
| العنوان: | A randomised, placebo-controlled, Phase II, dose-ranging trial of once-daily treatment with olodaterol, a novel long-acting β2-agonist, for 4 weeks in patients with chronic obstructive pulmonary disease |
|---|---|
| المؤلفون: | Maleki-Yazdi, M. Reza, Beck, Ekkehard, Hamilton, Alan L., Korducki, Lawrence, Koker, Paul, Fogarty, Charles |
| المصدر: | In Respiratory Medicine May 2015 109(5):596-605 |
| قاعدة البيانات: | ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 09546111 |
|---|---|
| DOI: | 10.1016/j.rmed.2015.02.012 |